Zomedica Corp.
ZOMDF · OTCMCIK 1684144fmd_0Y0ASWGNGSQWGTKGC69QZXBM6WManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Jan 01, 2016 to Sep 30, 2026, 40 periods
| Line item | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenues | – | – | – | – | 0 | 4 | 19 | 25 | 27 | 32 |
| Total interest income | – | – | – | – | – | 0 | 3 | – | – | – |
| Cost of revenue | – | – | – | – | 0 | 1 | 5 | 8 | 8 | 10 |
| Net interest income | – | – | – | – | – | 0 | 3 | – | – | – |
| Gross profit | – | – | – | – | 0 | 3 | 13 | 17 | 19 | 22 |
| Research and development | 2 | 3 | 10 | 10 | 8 | 2 | 3 | 6 | 7 | 7 |
| Selling, general and administrative | – | – | – | – | 9 | 23 | 33 | 43 | 47 | 43 |
| Operating income | (6) | (8) | (17) | (20) | (17) | (21) | (22) | (43) | (51) | (84) |
| Interest expense | – | – | – | 0 | 0 | 0 | 0 | 0 | – | – |
| Other non-operating income (expense) | – | – | – | – | – | 0 | (0) | 2 | 0 | (0) |
| Income before taxes | (6) | (8) | (17) | (20) | (17) | (21) | (19) | (36) | (48) | (82) |
| Income tax expense | – | – | – | – | 0 | (2) | (2) | (1) | (1) | (0) |
| Net income from continuing operations | – | – | – | – | (17) | (18) | (17) | (35) | (47) | (82) |
| Net income | (6) | (8) | (17) | (20) | (17) | (18) | (17) | (35) | (47) | (82) |